220 related articles for article (PubMed ID: 33000217)
1. Vitamin D receptor knockdown attenuates the antiproliferative, pro‑apoptotic and anti‑invasive effect of vitamin D by activating the Wnt/β‑catenin signaling pathway in papillary thyroid cancer.
Pang R; Xu Y; Hu X; Liu B; Yu J
Mol Med Rep; 2020 Nov; 22(5):4135-4142. PubMed ID: 33000217
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt/β-catenin pathway.
Corachán A; Ferrero H; Aguilar A; Garcia N; Monleon J; Faus A; Cervelló I; Pellicer A
Fertil Steril; 2019 Feb; 111(2):397-407. PubMed ID: 30458994
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D-induced vitamin D receptor expression induces tamoxifen sensitivity in MCF-7 stem cells via suppression of Wnt/β-catenin signaling.
Zheng W; Duan B; Zhang Q; Ouyang L; Peng W; Qian F; Wang Y; Huang S
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30314996
[No Abstract] [Full Text] [Related]
4. Potential Use of 1-25-dihydroxyvitamin D in the Diagnosis and Treatment of Papillary Thyroid Cancer.
Zhang T; Zhang H; He L; Wang Z; Dong W; Sun W; Zhang P
Med Sci Monit; 2018 Mar; 24():1614-1623. PubMed ID: 29553126
[TBL] [Abstract][Full Text] [Related]
5. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway.
Zhong J; Lin R; Wang G; Lin L; Ruan S; Liu W
Tissue Cell; 2022 Apr; 75():101739. PubMed ID: 35066335
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor and progesterone receptor protein and gene expression in papillary thyroid carcinomas: associations with histological features.
Yavropoulou MP; Panagiotou G; Topouridou K; Karayannopoulou G; Koletsa T; Zarampoukas T; Goropoulos A; Chatzaki E; Yovos JG; Pazaitou-Panayiotou K
J Endocrinol Invest; 2017 Dec; 40(12):1327-1335. PubMed ID: 28589382
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxy vitamin D3 inhibits the Ras-MEK-ERK pathway and regulates proliferation and apoptosis of papillary thyroid carcinoma.
Li B; Lv L; Li W
Steroids; 2020 Jul; 159():108585. PubMed ID: 31982425
[TBL] [Abstract][Full Text] [Related]
8. A sorafenib-sparing effect in the treatment of thyroid carcinoma cells attained by co-treatment with a novel isoflavone derivative and 1,25 dihydroxyvitamin D3.
Izkhakov E; Sharon O; Knoll E; Aizic A; Fliss DM; Kohen F; Stern N; Somjen D
J Steroid Biochem Mol Biol; 2018 Sep; 182():81-86. PubMed ID: 29702263
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
Zhou Z; Liu Y; Ma M; Chang L
Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D modulates E-cadherin turnover by regulating TGF-β and Wnt signalings during EMT-mediated myofibroblast differentiation in A459 cells.
Sari E; Oztay F; Tasci AE
J Steroid Biochem Mol Biol; 2020 Sep; 202():105723. PubMed ID: 32603782
[TBL] [Abstract][Full Text] [Related]
12. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
Geng Q; Deng H; Fu J; Cui F
Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034
[TBL] [Abstract][Full Text] [Related]
13. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D in thyroid tumorigenesis and development.
Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
[TBL] [Abstract][Full Text] [Related]
15. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
16. KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells.
Pereira F; Barbáchano A; Silva J; Bonilla F; Campbell MJ; Muñoz A; Larriba MJ
Hum Mol Genet; 2011 Dec; 20(23):4655-65. PubMed ID: 21890490
[TBL] [Abstract][Full Text] [Related]
17. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors.
Clinckspoor I; Hauben E; Verlinden L; Van den Bruel A; Vanwalleghem L; Vander Poorten V; Delaere P; Mathieu C; Verstuyf A; Decallonne B
J Histochem Cytochem; 2012 Jul; 60(7):502-11. PubMed ID: 22511602
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D less-calcemic analog modulates the expression of estrogen receptors, vitamin D receptor and 1α-hydroxylase 25-hydroxy vitamin D in human thyroid cancer cell lines.
Somjen D; Grafi-Cohen M; Posner GH; Sharon O; Kraiem Z; Stern N
J Steroid Biochem Mol Biol; 2013 Jul; 136():80-2. PubMed ID: 23059472
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D inhibits lymphangiogenesis through VDR-dependent mechanisms.
Yazdani S; Poosti F; Toro L; Wedel J; Mencke R; Mirković K; de Borst MH; Alexander JS; Navis G; van Goor H; van den Born J; Hillebrands JL
Sci Rep; 2017 Mar; 7():44403. PubMed ID: 28303937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
